Quarterly report pursuant to Section 13 or 15(d)

Shareholders' Equity - Non-Vested Restricted Stock Units Activity (Details)

v3.21.2
Shareholders' Equity - Non-Vested Restricted Stock Units Activity (Details)
shares in Thousands
9 Months Ended
Oct. 30, 2021
$ / shares
shares
Market Based Restricted Stock Units [Member]  
Summary of changes in Company's non-vested restricted stock during period [Roll Forward]  
Non-vested restricted stock shares outstanding at beginning of period | shares 60
Granted, shares | shares 0
Vested, shares | shares 0
Forfeited, shares | shares 0
Non-vested restricted stock shares outstanding at end of period | shares 60
Summary of changes in Company's non-vested restricted stock during period, weighted average grant date fair value [Roll Forward]  
Non-vested restricted stock shares outstanding at beginning of period, weighted average grant date fair value per share | $ / shares $ 3.52
Granted, weighted average grant date fair value per share | $ / shares 0
Vested, weighted average grant date fair value per share | $ / shares 0
Forfeited, weighted average grant date fair value per share | $ / shares 0
Non-vested restricted stock shares outstanding at end of period, weighted average grant date fair value per share | $ / shares $ 3.52
Restricted Stock Units Time Based [Member]  
Summary of changes in Company's non-vested restricted stock during period [Roll Forward]  
Non-vested restricted stock shares outstanding at beginning of period | shares 736
Granted, shares | shares 824
Vested, shares | shares (336)
Forfeited, shares | shares (42)
Non-vested restricted stock shares outstanding at end of period | shares 1,182
Summary of changes in Company's non-vested restricted stock during period, weighted average grant date fair value [Roll Forward]  
Non-vested restricted stock shares outstanding at beginning of period, weighted average grant date fair value per share | $ / shares $ 4.03
Granted, weighted average grant date fair value per share | $ / shares 9.33
Vested, weighted average grant date fair value per share | $ / shares 5.83
Forfeited, weighted average grant date fair value per share | $ / shares 4.15
Non-vested restricted stock shares outstanding at end of period, weighted average grant date fair value per share | $ / shares $ 7.39
Restricted Stock Units (RSUs) [Member]  
Summary of changes in Company's non-vested restricted stock during period [Roll Forward]  
Non-vested restricted stock shares outstanding at beginning of period | shares 942
Granted, shares | shares 901
Vested, shares | shares (336)
Forfeited, shares | shares (42)
Non-vested restricted stock shares outstanding at end of period | shares 1,465
Summary of changes in Company's non-vested restricted stock during period, weighted average grant date fair value [Roll Forward]  
Non-vested restricted stock shares outstanding at beginning of period, weighted average grant date fair value per share | $ / shares $ 3.64
Granted, weighted average grant date fair value per share | $ / shares 9.28
Vested, weighted average grant date fair value per share | $ / shares 5.83
Forfeited, weighted average grant date fair value per share | $ / shares 4.15
Non-vested restricted stock shares outstanding at end of period, weighted average grant date fair value per share | $ / shares $ 6.74
Performance Based Units [ Member]  
Summary of changes in Company's non-vested restricted stock during period [Roll Forward]  
Non-vested restricted stock shares outstanding at beginning of period | shares 146
Granted, shares | shares 77
Non-vested restricted stock shares outstanding at end of period | shares 223
Summary of changes in Company's non-vested restricted stock during period, weighted average grant date fair value [Roll Forward]  
Non-vested restricted stock shares outstanding at beginning of period, weighted average grant date fair value per share | $ / shares $ 1.69
Granted, weighted average grant date fair value per share | $ / shares 8.72
Non-vested restricted stock shares outstanding at end of period, weighted average grant date fair value per share | $ / shares $ 4.13